PolyPid Ltd.
NASDAQ: PYPD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dikla Czaczkes Akselbrad
- Employees
- 57
- Headquarters
- Petah Tikva, Israel
- IPO year
- 2020
- Market cap
- $48.5M
- Website
- https://www.polypid.com
Loading PYPD…
Loading profile data…Frequently asked questions about PYPD
What does PolyPid Ltd. (PYPD) do?
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product can...
Where does PYPD trade?
PolyPid Ltd. (PYPD) trades on the NASDAQ Global Market.
What sector is PYPD in?
PolyPid Ltd. (PYPD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PolyPid Ltd.?
Dikla Czaczkes Akselbrad is the chief executive officer of PolyPid Ltd. (PYPD).
Where is PolyPid Ltd. headquartered?
PolyPid Ltd. is headquartered in Israel.
Does PYPD pay a dividend?
PolyPid Ltd. (PYPD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PYPD go public?
PolyPid Ltd. (PYPD) completed its initial public offering in 2020.